Biochemical and genetic characterization of type I familial amyloidotic polyneuropathy

Masamitsu Nakazato, Hiroyuki Sasaki, Hirokazu Furuya, Yoshiyuki Sakaki, Teruyuki Kurihara, Shigeru Matsukura, Kenji Kangawa, Hisayuki Matsuo

Research output: Contribution to journalShort survey

15 Citations (Scopus)

Abstract

Type I familial amyloidotic polyneuropathy is an autosomal dominant, inherited systemic amyloidosis characterized initially by dissociated sensory disturbance and autonomic dysfunction. The amyloid fibril protein seen in patients of Portuguese, Japanese, and Swedish descent in the U.S. mainly consists of a variant form of transthyretin (also called prealbumin) with the substitution of methionine for valine at position 30. Methods have been developed to detect this variant transthyretin in the serum, and to detect a base change in a mutated transthyretin gene. The biochemical and genetic abnormalities in transthyretin are completely linked to the clinical diagnosis of type I familial amylodotic polyneuropathy. These diagnostic methods may allow early diagnosis and genetic counseling to avoid transmission of this intractable disorder to the next generation.

Original languageEnglish
Pages (from-to)596-598
Number of pages3
JournalAnnals of Neurology
Volume21
Issue number6
DOIs
Publication statusPublished - Jan 1 1987

Fingerprint

Prealbumin
Polyneuropathies
Molecular Biology
Amyloidogenic Proteins
Genetic Counseling
Valine
Amyloidosis
Amyloid
Methionine
Early Diagnosis
Serum
Genes

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

Nakazato, M., Sasaki, H., Furuya, H., Sakaki, Y., Kurihara, T., Matsukura, S., ... Matsuo, H. (1987). Biochemical and genetic characterization of type I familial amyloidotic polyneuropathy. Annals of Neurology, 21(6), 596-598. https://doi.org/10.1002/ana.410210612

Biochemical and genetic characterization of type I familial amyloidotic polyneuropathy. / Nakazato, Masamitsu; Sasaki, Hiroyuki; Furuya, Hirokazu; Sakaki, Yoshiyuki; Kurihara, Teruyuki; Matsukura, Shigeru; Kangawa, Kenji; Matsuo, Hisayuki.

In: Annals of Neurology, Vol. 21, No. 6, 01.01.1987, p. 596-598.

Research output: Contribution to journalShort survey

Nakazato, M, Sasaki, H, Furuya, H, Sakaki, Y, Kurihara, T, Matsukura, S, Kangawa, K & Matsuo, H 1987, 'Biochemical and genetic characterization of type I familial amyloidotic polyneuropathy', Annals of Neurology, vol. 21, no. 6, pp. 596-598. https://doi.org/10.1002/ana.410210612
Nakazato, Masamitsu ; Sasaki, Hiroyuki ; Furuya, Hirokazu ; Sakaki, Yoshiyuki ; Kurihara, Teruyuki ; Matsukura, Shigeru ; Kangawa, Kenji ; Matsuo, Hisayuki. / Biochemical and genetic characterization of type I familial amyloidotic polyneuropathy. In: Annals of Neurology. 1987 ; Vol. 21, No. 6. pp. 596-598.
@article{ece441b22925407ca722307a2dbb5233,
title = "Biochemical and genetic characterization of type I familial amyloidotic polyneuropathy",
abstract = "Type I familial amyloidotic polyneuropathy is an autosomal dominant, inherited systemic amyloidosis characterized initially by dissociated sensory disturbance and autonomic dysfunction. The amyloid fibril protein seen in patients of Portuguese, Japanese, and Swedish descent in the U.S. mainly consists of a variant form of transthyretin (also called prealbumin) with the substitution of methionine for valine at position 30. Methods have been developed to detect this variant transthyretin in the serum, and to detect a base change in a mutated transthyretin gene. The biochemical and genetic abnormalities in transthyretin are completely linked to the clinical diagnosis of type I familial amylodotic polyneuropathy. These diagnostic methods may allow early diagnosis and genetic counseling to avoid transmission of this intractable disorder to the next generation.",
author = "Masamitsu Nakazato and Hiroyuki Sasaki and Hirokazu Furuya and Yoshiyuki Sakaki and Teruyuki Kurihara and Shigeru Matsukura and Kenji Kangawa and Hisayuki Matsuo",
year = "1987",
month = "1",
day = "1",
doi = "10.1002/ana.410210612",
language = "English",
volume = "21",
pages = "596--598",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Biochemical and genetic characterization of type I familial amyloidotic polyneuropathy

AU - Nakazato, Masamitsu

AU - Sasaki, Hiroyuki

AU - Furuya, Hirokazu

AU - Sakaki, Yoshiyuki

AU - Kurihara, Teruyuki

AU - Matsukura, Shigeru

AU - Kangawa, Kenji

AU - Matsuo, Hisayuki

PY - 1987/1/1

Y1 - 1987/1/1

N2 - Type I familial amyloidotic polyneuropathy is an autosomal dominant, inherited systemic amyloidosis characterized initially by dissociated sensory disturbance and autonomic dysfunction. The amyloid fibril protein seen in patients of Portuguese, Japanese, and Swedish descent in the U.S. mainly consists of a variant form of transthyretin (also called prealbumin) with the substitution of methionine for valine at position 30. Methods have been developed to detect this variant transthyretin in the serum, and to detect a base change in a mutated transthyretin gene. The biochemical and genetic abnormalities in transthyretin are completely linked to the clinical diagnosis of type I familial amylodotic polyneuropathy. These diagnostic methods may allow early diagnosis and genetic counseling to avoid transmission of this intractable disorder to the next generation.

AB - Type I familial amyloidotic polyneuropathy is an autosomal dominant, inherited systemic amyloidosis characterized initially by dissociated sensory disturbance and autonomic dysfunction. The amyloid fibril protein seen in patients of Portuguese, Japanese, and Swedish descent in the U.S. mainly consists of a variant form of transthyretin (also called prealbumin) with the substitution of methionine for valine at position 30. Methods have been developed to detect this variant transthyretin in the serum, and to detect a base change in a mutated transthyretin gene. The biochemical and genetic abnormalities in transthyretin are completely linked to the clinical diagnosis of type I familial amylodotic polyneuropathy. These diagnostic methods may allow early diagnosis and genetic counseling to avoid transmission of this intractable disorder to the next generation.

UR - http://www.scopus.com/inward/record.url?scp=0023182652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023182652&partnerID=8YFLogxK

U2 - 10.1002/ana.410210612

DO - 10.1002/ana.410210612

M3 - Short survey

C2 - 3037992

AN - SCOPUS:0023182652

VL - 21

SP - 596

EP - 598

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 6

ER -